Clinical Trials Logo

Premature Ejaculation clinical trials

View clinical trials related to Premature Ejaculation.

Filter by:
  • Recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06172855 Recruiting - Clinical trials for Premature Ejaculation

The Study on the Effectiveness and Safety of Electroacupuncture at ST36 in Treating Primary Premature Ejaculation

Start date: January 1, 2024
Phase: N/A
Study type: Interventional

A pilot prospective single-arm cohort study on the Effectiveness and Safety of Electroacupuncture at ST36(Zusanli) in Treating Primary Premature Ejaculation

NCT ID: NCT05749614 Recruiting - Clinical trials for Premature Ejaculation

Precise Use of Lidocaine Cream to Treat Primary Premature Ejaculation

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

This study aimed to evaluate the efficacy and safety of applying 5% lidocaine cream to the sensitive area of the glans penis after its precise localization under the penile biological vibration threshold test for the treatment of primary premature ejaculation.

NCT ID: NCT04941690 Recruiting - Clinical trials for Erectile Dysfunction

Erectile Dysfunction, Psychological Disorders, and Sexual Performance Among Men Seeking Medical Help for Fertility

Start date: June 26, 2021
Phase:
Study type: Observational

According to the World Health Organization (WHO) and the World Association for Sexual Health (WAS), sexual health is directly related to everyone's mental health and quality of life. Sexuality is innate to humans and is closely linked to their reproduction. Thus, a correlation between unmet fertility desires and sexual disorders can be observed in infertile couples. In fact, sexual intercourse itself will not be as natural in most cases and will preferentially occur during the "reproductive window". Thus, sexuality will be deprived of recreational and erotic activities, and sexuality will be used only for reproduction. For many men, sexual intercourse will become coercive, repetitive and mechanical, offering little emotion. The interactions between infertility and wife recurrent miscarriage in sexuality are numerous and complex. Many men will perceive their infertility as a loss of masculinity and virility and may feel low self-esteem and depression, in addition, Decreased sperm quality may lead to anxiety in men, which may eventually lead to temporary Sexual Dysfunction (SD).Therefore, the need to identify SD and its severity is crucial for infertile men before receiving individualized male treatment.

NCT ID: NCT04703127 Recruiting - Clinical trials for Premature Ejaculation

Effectiveness and Tolerability of the On-demand Use of Combined Dapoxetine With Tadalafil and Combined Dapoxetine With Lidocaine 5% Spray in Treatment of Patients With Lifelong Premature Ejaculation and Non-responding to Dapoxetine Alone.

PE
Start date: March 30, 2020
Phase: Phase 3
Study type: Interventional

Therefore, this study will aim to assess the effectiveness and tolerability of the on-demand use of combined dapoxetine with tadalafil and combined dapoxetine with lidocaine 5% spray in treatment of patients with lifelong premature ejaculation and non-responding to dapoxetine alone.

NCT ID: NCT04235192 Recruiting - Clinical trials for Premature Ejaculation

A Multicenter Case-control Study of Risk Factors for Premature Ejaculation in China's Shaanxi Province

Start date: July 31, 2019
Phase:
Study type: Observational

Through a multicenter case-control study on the risk factors of premature ejaculation in Shaanxi, to find out the related factors of the occurrence and development of premature ejaculation, to provide reference for personalized treatment, in order to improve the quality of sexual life of patients and partners.

NCT ID: NCT04207723 Recruiting - Clinical trials for Premature Ejaculation

Transcutaneous Posterior Tibial Nerve Stimulation for Premature Ejaculation

Start date: July 15, 2020
Phase: N/A
Study type: Interventional

Objective: Evaluate the effectiveness and safety of transcutaneous electrostimulation of the posterior tibial nerve alone and combined with standard pharmacological treatment, in men with primary premature ejaculation, compared to standard pharmacological treatment. Patients and methods: Randomized controlled clinical trial. Patients diagnosed with premature ejaculation attending Boston Medical Group clinics in Colombia and Spain will be included. Participants will be assigned by randomization to one of three treatment groups: - Group 1: Tens + placebo drug therapy - Group 2: Standard treatment (paroxetine 20 mg) + placebo therapy - Group 3: Tens therapy + standard treatment (paroxetine mg) The change in intravaginal latency time measured with the couple's sustained stopwatch, the change in the PEDT scale, the perception of the change in their initial condition after treatment (Global Clinical impression of change scale), and the change in different domains of the EP (PEP Scale - Profile Ejaculation Premature) at the end of treatment (week 12) and at three months of follow-up (week 24).

NCT ID: NCT03629769 Recruiting - Clinical trials for Premature Ejaculation

Effects of Proxelan Somministration in Patients With Chronic Prostatitis

Start date: February 16, 2017
Phase: Phase 3
Study type: Interventional

The purpose of the study is to determinate the antinflammatory effects of the Proxelan on a cohort of patients affected by prostatitis'like symptoms and clinical evidence of abacterical prostatistis, trough a significative improvements of pain symptoms according to the NIH-CPSI questionnaire items, spermatozoa motility/concentration variations and the semen cytokines level decrease.

NCT ID: NCT03583112 Recruiting - Clinical trials for Premature Ejaculation

Investigation of the Changes of Brain Structure and Function in Premature Ejaculation Patients and the Effects of Dapoxetine on Central Neural Activity in Premature Ejaculation Patients

Start date: July 10, 2018
Phase: N/A
Study type: Interventional

Lifelong premature ejaculation (LPE) is a common male sexual dysfunction with a high prevalence in global. Up to now, the etiology of LPE remains unclear. In recent years, dapoxetine, a highly potent serotonin-transporter inhibitor, has been used for treating premature ejaculation. However, the underlying mechanism of dapoxetine was unknown. Recently, with widespread use of neuroimaging techniques, like positron emission tomography and magnetic resonance imaging (MRI) in basic science, researchers can acquire human data on cerebral base of human sexual behavior, not only in normal subjects but also in patients with sexual dysfunction. Therefore, in order to further understand the biological mechanism of LPE and the brain targets of dapoxetine, the present study would investigate the brain changes of LPE and the effect of dapoxetine on brain activation by using MRI technology.

NCT ID: NCT03177226 Recruiting - Clinical trials for Premature Ejaculation

Safety & Feasibility of Functional Electrical Stimulation for The Treatment of Premature Ejaculation

Start date: January 2017
Phase: N/A
Study type: Interventional

Prospective, non-randomized, controlled, single-center study, to evaluate the efficacy of applied nominal electrical stimulation parameters given to premature ejaculation (PE) patients in order to prolong the ejaculatory latency time which will eventually increase the quality of their sexual life.

NCT ID: NCT02581826 Recruiting - Clinical trials for Premature Ejaculation

Safety and Efficacy of Silodosin in the Treatment of Premature Ejaculation

Start date: October 2013
Phase: Phase 2
Study type: Interventional

The objectives of the present study aims to evaluate the safety and efficacy of Silodosin in a population of patients wih Premature Ejaculation (PE). Coupled with efficient diagnosis, it is hoped that the newer agent will improve the quality of life for patients who suffer from Premature Ejaculation (PE).